<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39977078</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>08</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1606-7916</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>4, jul-ago</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>22</Day></PubDate></JournalIssue><Title>Salud publica de Mexico</Title><ISOAbbreviation>Salud Publica Mex</ISOAbbreviation></Journal><ArticleTitle>[Not Available].</ArticleTitle><Pagination><StartPage>530</StartPage><EndPage>538</EndPage><MedlinePgn>530-538</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.21149/16209</ELocationID><Abstract><AbstractText Label="OBJETIVO" NlmCategory="OBJECTIVE">Actualizar las prevalencias de diabetes tipo 2 (DT2), estimar las cascadas de tamizaje y atenci&#xf3;n de la DT2 en poblaci&#xf3;n adulta mexicana. Material y m&#xe9;todos. Se utiliz&#xf3; la Encuesta Nacional de Salud y Nutrici&#xf3;n 2023. Se estim&#xf3; la cascada de tamizaje, utilizando la poblaci&#xf3;n elegible seg&#xfa;n la NOM-015-SSA2-2010 y se estim&#xf3; la cascada de atenci&#xf3;n de DT2 en las personas con diagn&#xf3;stico.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="RESULTS">La prevalencia de DT2 fue de 18.4% (12.4% diagnosticada, 6.0% no diagnosticada). El 83% de la poblaci&#xf3;n adulta sin DT2 ten&#xed;a factores de riesgo que la hac&#xed;an elegible a tamizaje sangu&#xed;neo. El 27.7% de poblaci&#xf3;n elegible fue tamizada en el &#xfa;ltimo a&#xf1;o (meta 33.3%). De las personas con diagn&#xf3;stico de DT2, 72.8% asisti&#xf3; a consulta al menos una vez el &#xfa;ltimo a&#xf1;o, 92.8% estaba en tratamiento farmacol&#xf3;gico, 77.9% usaba el tratamiento regularmente y 25.8% ten&#xed;a niveles gluc&#xe9;micos controlados. Las personas que realizaron los tres pasos de atenci&#xf3;n (seguimiento, tratamiento y tratamiento regular) alcanzaron un control gluc&#xe9;mico ligeramente mayor (34.4%). Conclusi&#xf3;n. M&#xe9;xico enfrenta retos importantes para garantizar el tamizaje, la atenci&#xf3;n y el control gluc&#xe9;mico. Se proponen varias acciones para mejorar la detecci&#xf3;n y control a partir de la evidencia generada con las cascadas de tamizaje y atenci&#xf3;n.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Basto-Abreu</LastName><ForeName>Ana</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Salud Poblacional, Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico.. ana.basto@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes-Garcia</LastName><ForeName>Alan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Salud Poblacional, Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico.. alambertocdc@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stern</LastName><ForeName>Dalia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Salud Poblacional, Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico. Conahcyt, Centro de Investigaci&#xf3;n en Salud Poblacional, Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico.. dalia.stern@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Torres-Ibarra</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Salud Poblacional, Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico.. leticia.torres@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Mart&#xed;nez</LastName><ForeName>Rosalba</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Salud Poblacional, Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico.. rrojas@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar-Salinas</LastName><ForeName>Carlos A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Direcci&#xf3;n de Investigaci&#xf3;n, Instituto Nacional de Ciencias M&#xe9;dicas y Nutrici&#xf3;n Salvador Zubir&#xe1;n. Ciudad de M&#xe9;xico, M&#xe9;xico.. caguilarsalinas@yahoo.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero-Mart&#xed;nez</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Evaluaci&#xf3;n y Encuestas, Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico.. martin.romero@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos-Nonato</LastName><ForeName>Ismael</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Nutrici&#xf3;n y Salud, Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico.. icampos@insp.mx.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Ridaura</LastName><ForeName>Ruy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Secretar&#xed;a de Salud. M&#xe9;xico.. rlridaura@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrientos-Guti&#xe9;rrez</LastName><ForeName>Tonatiuh</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n en Salud Poblacional, Instituto Nacional de Salud P&#xfa;blica. Cuernavaca, Morelos, M&#xe9;xico.. tbarrientos@insp.mx.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Cascadas de tamizaje y atenci&#xf3;n de la diabetes tipo 2 en M&#xe9;xico.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Mexico</Country><MedlineTA>Salud Publica Mex</MedlineTA><NlmUniqueID>0404371</NlmUniqueID><ISSNLinking>0036-3634</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008800" MajorTopicYN="N" Type="Geographic">Mexico</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003924" MajorTopicYN="Y">Diabetes Mellitus, Type 2</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="Y">Mass Screening</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009749" MajorTopicYN="N">Nutrition Surveys</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085002" MajorTopicYN="N">Glycemic Control</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>18</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>20</Day><Hour>11</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39977078</ArticleId><ArticleId IdType="doi">10.21149/16209</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">23159793</PMID><DateCompleted><Year>2014</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1275</ISSN><JournalIssue CitedMedium="Internet"><Volume>45</Volume><Issue>4</Issue><PubDate><Year>2013</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Atencion primaria</Title><ISOAbbreviation>Aten Primaria</ISOAbbreviation></Journal><ArticleTitle>[Diagnosis of heart failure with preserved or reduced ejection fraction in a one-stop clinic].</ArticleTitle><Pagination><StartPage>184</StartPage><EndPage>192</EndPage><MedlinePgn>184-92</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aprim.2012.09.009</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0212-6567(12)00383-6</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">a) To assess the usefulness of a one-stop clinic for the diagnosis of outpatients with new onset heart failure; b) to characterize these patients comparing preserved (HF-PEF) versus reduced ejection fraction (HF-REF), and c) to determine brain natriuretic peptide (BNP) cut-off limit to identify HF in outpatients.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Observational descriptive study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Primary care.</AbstractText><AbstractText Label="PARTICIPANTS AND MEASUREMENTS" NlmCategory="METHODS">A total of 143 outpatients with new onset HF were assessed in a one-stop clinic. A cardiologist evaluation, electrocardiogram, chest X-ray, BNP, and echocardiography (diastolic and systolic study) were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Almost two-thirds (65.7%) were diagnosed with HF: 67% with HF-PEF and 33% HF-REF. Women (71.4% versus 38.7%, P=.002), presence of swelling ankles (61.9% versus 35.5%, P=.016) and higher body mass index (29.8&#xb1;5.1 versus 27.2&#xb1;5.0 P=.021) were more frequent in the first group of patients. Echocardiographic signs of diastolic dysfunction and pulmonary hypertension were found in both groups, with higher values of BNP (153.3&#xb1;123.1 versus 400.8&#xb1;579.8 P=.025) and troponin I (0.024&#xb1;0.019 versus 0.071&#xb1;0.12, P=.037) in HF-REF patients. Female gender and swelling ankles were predictors of HF-PEF in the multivariate analysis, while Q waves and higher values of BNP and heart rate were predictors of HF-REF. A cut-off value of 60.12 pg/ml for BNP provided 83% sensitivity, 84% specificity (AUC=0.898; 95% CI; 0.848-0.948; P &lt;.001).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The one-stop HF clinic has diagnosed and characterized outpatients with new onset HF and high prevalence of HF-PEF. The cut-off value of 60.12 pg/ml for BNP provides high sensitivity and specificity to identify HF in this population.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Espa&#xf1;a, S.L. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andrea</LastName><ForeName>Rut</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Instituto del T&#xf3;rax, Hospital Cl&#xed;nic-Institut d'Investigacions Biom&#xe8;diques August Pi i Sunyer (IBIDAPS), Universidad de Barcelona, Barcelona, Espa&#xf1;a. randrea@clinic.ub.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Falces</LastName><ForeName>Carlos</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Sanchis</LastName><ForeName>Laura</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Sitges</LastName><ForeName>Marta</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Heras</LastName><ForeName>Magda</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Brugada</LastName><ForeName>Josep</ForeName><Initials>J</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Diagn&#xf3;stico de la insuficiencia card&#xed;aca con fracci&#xf3;n de eyecci&#xf3;n preservada o reducida mediante una consulta de alta resoluci&#xf3;n.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2012</Year><Month>11</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Aten Primaria</MedlineTA><NlmUniqueID>9111075</NlmUniqueID><ISSNLinking>0212-6567</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="N">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000554" MajorTopicYN="N">Ambulatory Care Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="Y">Stroke Volume</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="OBJETIVOS"><i>a)</i> Valorar la aplicabilidad de una consulta de alta resoluci&#xf3;n (CAR) para el diagn&#xf3;stico de pacientes ambulatorios con insuficiencia card&#xed;aca (IC) de inicio; <i>b)</i> caracterizar a los pacientes con IC y fracci&#xf3;n de eyecci&#xf3;n preservada (ICFE-P) comparados con los de fracci&#xf3;n de eyecci&#xf3;n reducida (ICFE-R), y <i>c)</i> determinar el nivel de p&#xe9;ptido natriur&#xe9;tico tipo B (PNB) para identificar la IC en esta poblaci&#xf3;n.</AbstractText><AbstractText Label="DISE&#xd1;O">Estudio longitudinal observacional descriptivo.</AbstractText><AbstractText Label="EMPLAZAMIENTO">Atenci&#xf3;n primaria especializada.</AbstractText><AbstractText Label="PARTICIPANTES Y MEDICIONES">Ciento cuarenta y tres pacientes con s&#xed;ntomas iniciales de IC fueron incluidos en una CAR-IC con evaluaci&#xf3;n cl&#xed;nica, electrocardiograma, radiograf&#xed;a de t&#xf3;rax, PNB y ecocardiograma.</AbstractText><AbstractText Label="RESULTADOS">Se diagnostic&#xf3; IC en 65,7% de los pacientes: 67% ICFE-P y 33% ICFE-R. La mayor&#xed;a de pacientes con ICFE-P eran mujeres (71,4 versus 38,7%; p&#xa0;=&#xa0;0,002), con m&#xe1;s edemas maleolares (61,9% versus 35,5%; p&#xa0;=&#xa0;0,016) e &#xed;ndice de masa corporal (29,8&#xa0;&#xb1;&#xa0;5,1 versus 27,2&#xa0;&#xb1;&#xa0;5,0; p&#xa0;=&#xa0;0,021). Ambos presentaron signos ecocardiogr&#xe1;ficos de disfunci&#xf3;n diast&#xf3;lica e hipertensi&#xf3;n pulmonar, con PNB (153,3&#xa0;&#xb1;&#xa0;123,1 versus 400,8&#xa0;&#xb1;&#xa0;579,8; p&#xa0;=&#xa0;0,025) y troponina I (0,024&#xa0;&#xb1;&#xa0;0,019 versus 0,071&#xa0;&#xb1;&#xa0;0,12; p&#xa0;=&#xa0;0,037) m&#xe1;s elevados en ICFE-R. Resultaron predictores de ICFE-P el sexo femenino y los edemas maleolares, mientras que la onda Q, los valores elevados de PNB y la frecuencia card&#xed;aca lo fueron de ICFE-R. El punto de corte de PNB&#xa0;=&#xa0;60,12 pg/ml identific&#xf3; IC con sensibilidad del 83% y especificidad del 84% (ABC&#xa0;=&#xa0;0,898; IC 95% [0,848-0,948]; p&#xa0;&lt;&#xa0;0,001).</AbstractText><AbstractText Label="CONCLUSIONES">La CAR-IC permiti&#xf3; el diagn&#xf3;stico r&#xe1;pido y la caracterizaci&#xf3;n de la IC de inicio, con mayor prevalencia de ICFE-P, en pacientes ambulatorios. El valor de PNB 60,12 pg/ml ofreci&#xf3; una sensibilidad y especificidad elevadas para identificar la IC en esta poblaci&#xf3;n.</AbstractText><CopyrightInformation>Copyright &#xa9; 2012 Elsevier Espa&#xf1;a, S.L. All rights reserved.</CopyrightInformation></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>6</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2012</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2012</Year><Month>11</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2012</Year><Month>11</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">23159793</ArticleId><ArticleId IdType="pmc">PMC6985517</ArticleId><ArticleId IdType="doi">10.1016/j.aprim.2012.09.009</ArticleId><ArticleId IdType="pii">S0212-6567(12)00383-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Anguita M., Crespo M., de Teresa E., Jimenez M., Alonso-Pulp&#xf3;n L., Mu&#xf1;iz J. Prevalencia de la insuficiencia card&#xed;aca en la poblaci&#xf3;n general espa&#xf1;ola mayor de 45 a&#xf1;os. Estudio PRICE. Rev Esp Cardiol. 2008;61:1041&#x2013;1049.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J. 2008;29:2388&#x2013;2442.</Citation><ArticleIdList><ArticleId IdType="pubmed">18799522</ArticleId></ArticleIdList></Reference><Reference><Citation>Bursi F., Weston S.A., Redfield M.M., Jacobsen S.J., Pakhomow S., Nkomo V.T. Systolic and diastolic heart failure in the community. JAMA. 2006;296:2209&#x2013;2216.</Citation><ArticleIdList><ArticleId IdType="pubmed">17090767</ArticleId></ArticleIdList></Reference><Reference><Citation>Grupo de Trabajo de Insuficiencia Card&#xed;aca de la Sociedad Espa&#xf1;ola de Medicina Interna (SEMI) La insuficiencia card&#xed;aca en los servicios de medicina interna (estudio SEMI-IC) Med Clin (Barc) 2002;118:605&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">12028912</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulus W.J., Tschope C., Sanderson J.E., Rusconi C., Flaschskampf F.A., Rademakers F.E. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J. 2007;28:2539&#x2013;2550.</Citation><ArticleIdList><ArticleId IdType="pubmed">17428822</ArticleId></ArticleIdList></Reference><Reference><Citation>Falces C., Andrea R., Heras M., Veh&#xed; C., Sorribes M., Sanchis L. Integraci&#xf3;n entre cardiolog&#x131;&#xed;a y atenci&#xf3;n primaria: impacto sobre la pr&#xe1;ctica cl&#xed;nica. Rev Esp Cardiol. 2011;64:564&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">21640459</ArticleId></ArticleIdList></Reference><Reference><Citation>Falces C., Sadurn&#xed; J., Monell J., Andrea R., Ylla M., Moleiro A. Consulta inmediata ambulatoria de alta resoluci&#xf3;n en Cardiolog&#xed;a: 10 a&#xf1;os de experiencia. Rev Esp Cardiol. 2008;61:530&#x2013;533.</Citation><ArticleIdList><ArticleId IdType="pubmed">18462657</ArticleId></ArticleIdList></Reference><Reference><Citation>Falces C., L&#xf3;pez-Cabezas C., Andrea R., Arnau A., Ylla M., Sadurn&#xed; J. Intervenci&#xf3;n educativa para mejorar la adherencia al tratamiento y prevenir reingresos en pacientes con insuficiencia card&#xed;aca de edad avanzada. Med Clin (Barc) 2008;131:452&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">18928735</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotons C., Falces C., Alegre J., Ballarin E., Casanovas J., Cata T. Ensayo cl&#xed;nico aleatorizado para evaluar la efectividad de una intervenci&#xf3;n domiciliaria en pacientes con insuficiencia card&#xed;aca: estudio IC-DOM. Rev Esp Cardiol. 2009;62:400&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.S., Gona P., Vasan R.S., Larson M.G., Benjamin E.J., Wang T.J. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction. Insights from the Framingham Heart Study of the National Heart, Lung and Blood Institute. Circulation. 2009;119:3070&#x2013;3077.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2775498</ArticleId><ArticleId IdType="pubmed">19506115</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller W.L., Hartman K.A., Burritt M.F., Grill D.E., Jaffe A.S. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol. 2009;54:1715&#x2013;1721.</Citation><ArticleIdList><ArticleId IdType="pubmed">19850213</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsutamoto T., Kawahara C., Nishiyama K., Yamaji M., Fujii M., Yamamoto T. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure. Am Heart J. 2010;159:63&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">20102868</ArticleId></ArticleIdList></Reference><Reference><Citation>Luaces M., Cachofeiro V., Garc&#xed;a-Mu&#xf1;oz-Najar A., Medina M., Gonz&#xe1;lez N., Cancer E. Modificaciones anatomofuncionales del coraz&#xf3;n en la obesidad m&#xf3;rbida. Cambios tras la cirug&#xed;a bari&#xe1;trica. Rev Esp Cardiol. 2012;65:14&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">22015018</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuznetsova T., Herbots L., L&#xf3;pez B., Jin Y., Richar T., Thijs L. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail. 2009;2:105&#x2013;112.</Citation><ArticleIdList><ArticleId IdType="pubmed">19808325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bathia R.S., Tu J.V., Lee D.S., Austin P.C., Fang J., Haouzi A. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">16855266</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitzman D.W., Gardin J.M., Gottdiener J.S., Arnold A., Boineau R., Aurigemma G. Importance of heart failure with preserved systolic function in patients &gt; or =65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol. 2001;87:413&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">11179524</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones R.C., Francis G.S., Lauer M.S. Predictors of mortality in patients with heart failure and preserved systolic function in the DIG trial. J Am Coll Cardiol. 2004;44:1025&#x2013;1029.</Citation><ArticleIdList><ArticleId IdType="pubmed">15337214</ArticleId></ArticleIdList></Reference><Reference><Citation>Zile M.R., Gottdiener J.S., Hetzel S.J., McMurray J.J., Komajda M., McKelvie R. Prevalence and significance of alterations in cardiac estructure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011;124:2491&#x2013;2501.</Citation><ArticleIdList><ArticleId IdType="pubmed">22064591</ArticleId></ArticleIdList></Reference><Reference><Citation>Meta-analysis Research Group in Echocardiography (MeRGE) Heart Failure collaborators Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis. Eur Heart J. 2008:786&#x2013;792.</Citation><ArticleIdList><ArticleId IdType="pubmed">18617438</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenkorang J.N., Fox K.F., Collier T.J., Wood D.A. A rapid access cardiology service for chest pain, heart failure and arrhythmias accurately diagnoses cardiac disease and identifies patients at high risk: a prospective cohort study. Heart. 2006;92:1084&#x2013;1090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1861069</ArticleId><ArticleId IdType="pubmed">16387821</ArticleId></ArticleIdList></Reference><Reference><Citation>Montijano A.M., Caballero J. La consulta de acto &#xfa;nico en cardiolog&#xed;a. Rev Esp Cardiol. 2007;7:C30&#x2013;C36.</Citation></Reference><Reference><Citation>Fox K.F., Cowie M.R., Wood D.A., Coats A.J., Poole-Wilson P.A., Sutton G.C. A rapid access heart failure clinic promptly identifies heart failure and initiates appropriate therapy. Eur J Heart Fail. 2000:423&#x2013;429.</Citation><ArticleIdList><ArticleId IdType="pubmed">11113720</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam C.S.P., Lyass A., Kraigher-Krainet E., Massaro J., Lee D.S., Ho J.E. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation. 2011;124:24&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3257876</ArticleId><ArticleId IdType="pubmed">21670229</ArticleId></ArticleIdList></Reference><Reference><Citation>Zile M.R., Gaasch W.H., Anand I.S., Haass M., Little W.C., Miller A.B. Mode of death in patients with heart failure and a preserved ejection fraction. Results from the irbesartan in heart failure with preserved ejection fraction study (I-Preserve) Trial. Circulation. 2010;121:1393&#x2013;1405.</Citation><ArticleIdList><ArticleId IdType="pubmed">20231531</ArticleId></ArticleIdList></Reference><Reference><Citation>Anguita M., Castillo J.C., Ruiz M., Castillo F., Jim&#xe9;nez-Navarro M., Crespo M. Diferencias en el pron&#xf3;stico de la insuficiencia card&#xed;aca con funci&#xf3;n sist&#xf3;lica conservada o deprimida en pacientes mayores de 70 a&#xf1;os que toman bloqueadores beta. Rev Esp Cardiol. 2012;65:22&#x2013;28.</Citation></Reference><Reference><Citation>Verd&#xfa; J.M., Com&#xed;n-Colet J., Domingo M., Lup&#xf3;n J., G&#xf3;mez M., Molina L. Rapid Point-of-Care NT-proBNP Optimal Cut-off Point for Heart Failure Diagnosis in Primary Care. Rev Esp Cardiol. 2012;65:613&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">22541282</ArticleId></ArticleIdList></Reference><Reference><Citation>Westenbrink D B., Damman K., Rienstra M., Maass A.H., van der Meer P. Heart failure highlights in 2011. Eur J Heart Fail. 2012;14:1090&#x2013;1096.</Citation><ArticleIdList><ArticleId IdType="pubmed">22898804</ArticleId></ArticleIdList></Reference><Reference><Citation>Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J. 2012;33:1750&#x2013;1757.</Citation><ArticleIdList><ArticleId IdType="pubmed">21821849</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">19798842</PMID><DateCompleted><Year>2009</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0014-2565</ISSN><JournalIssue CitedMedium="Print"><Volume>209</Volume><Issue>2</Issue><PubDate><Year>2009</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Revista clinica espanola</Title><ISOAbbreviation>Rev Clin Esp</ISOAbbreviation></Journal><ArticleTitle>[Reason for a medical visit in the diagnosis of lung cancer. A review of 481 cases].</ArticleTitle><Pagination><StartPage>67</StartPage><EndPage>72</EndPage><MedlinePgn>67-72</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Lung cancer is the most frequent cancer death related cause in the world. Its clinical presentation usually corresponds to advanced stages. The indication of screening programs for the diagnosis in early phases has been debated for years.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To know the clinical characteristics in the presentation of the lung cancer in our health care area.</AbstractText><AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">All of the incident lung cancer cases for 3 years (January 1, 1997 to December 31, 1999) among those patients with usual residence in the Santiago de Compostela health care area were retrospectively collected from the available information in the Codification Service. The histological type was graded according to the World Health Organization classification. Date of death was obtained from the patient's clinical history, mortality record, or telephonic calls to the patient's home. The rest of the information was obtained from the clinical records of the patient and Pathology Service.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Four-hundred and eighty-one lung cancer cases were diagnosed (incident gross rate of 41.79 per 100,000 inhabitants and year). Median age was 66.9 years (interquartile range 60.5-74.4), 92.77% being males and 94.1% corresponding to smokers or former smokers. The most prevalent symptoms motivating the visit were general syndrome (20%), thoracic pain (19%) and hemoptisis (17%). A group of patients (56), fundamentally males, had an incidental diagnosis.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The incidence of lung cancer seems to be high in our health care area. The standard patient with lung cancer in this health care area is a 67-year-old, male, who smokes, diagnosed in advanced stages, who consults due to a general syndrome and/or chest pain. Some of the symptoms appear with significant gender differences. Likewise, there are differences between histologies, the high frequency of chest pain in adenocarcinoma being outstanding, although it is also the first cause for consultation in small cell lung cancer. On the contrary, hemoptisis, the most frequent consultation cause in squamous cell carcinoma and the general syndrome in the big cells type or with clinical-radiological diagnosis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Villamil Cajoto</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Hospitalizaci&#xf3;n a Domicilio, Complejo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, La Coru&#xf1;a,. Espa&#xf1;a. iago.villamil.cajoto@sergas.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a Prim</LastName><ForeName>J M</ForeName><Initials>JM</Initials></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez Barcala</LastName><ForeName>F J</ForeName><Initials>FJ</Initials></Author><Author ValidYN="Y"><LastName>Pose Reino</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Paredes Vila</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Calvo Alvarez</LastName><ForeName>U</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Vald&#xe9;s Cuadrado</LastName><ForeName>L</ForeName><Initials>L</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Motivo de consulta en el diagn&#xf3;stico de c&#xe1;ncer de pulm&#xf3;n. Revisi&#xf3;n de 481 casos.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Clin Esp</MedlineTA><NlmUniqueID>8608576</NlmUniqueID><ISSNLinking>0014-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008175" MajorTopicYN="N">Lung Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="N">Patient Acceptance of Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="Y">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>10</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19798842</ArticleId><ArticleId IdType="doi">10.1016/s0014-2565(09)70628-9</ArticleId><ArticleId IdType="pii">S0014-2565(09)70628-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">18570782</PMID><DateCompleted><Year>2008</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>12</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1579-2242</ISSN><JournalIssue CitedMedium="Internet"><Volume>61</Volume><Issue>6</Issue><PubDate><Year>2008</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Revista espanola de cardiologia</Title><ISOAbbreviation>Rev Esp Cardiol</ISOAbbreviation></Journal><ArticleTitle>[Heart failure in outpatients: comorbidities and management by different specialists. The EPISERVE Study].</ArticleTitle><Pagination><StartPage>611</StartPage><EndPage>619</EndPage><MedlinePgn>611-9</MedlinePgn></Pagination><Abstract><AbstractText Label="INTRODUCTION AND OBJECTIVES" NlmCategory="OBJECTIVE">The aim of the EPISERVE study was to investigate the clinical characteristics of heart failure in outpatients and its diagnostic and therapeutic management by cardiology, internal medicine and primary care specialists.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study involved 507 physicians working in primary care (n=181, 36%), cardiology (n=172, 34%) or internal medicine (n=154, 30%) who treated 2249 consecutive outpatients with heart failure between June and November 2005.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The prevalence of heart failure was 2% in primary care, 17% in cardiology and 12% in internal medicine. Hypertension or coronary disease was the cause in more than 80% of cases. The prevalence of comorbidities was high: atrial fibrillation, 46%; diabetes, 38%; obesity, 64%; dyslipidemia, 60%; anemia, 27%; and renal failure, 7%. In 40% of cases, systolic function was preserved (i.e., left ventricular ejection fraction &gt; or =45%). Echocardiographic and coronary angiographic studies were performed more frequently in patients seen in cardiology and in male patients. There were significant differences between men and women in pharmacologic treatment involving beta-blockers (55% vs. 44%, respectively; P&lt; .001), diuretics (88% vs. 92%, respectively; P&lt; .01) and statins (57% vs. 47%, respectively; P&lt; .001). Only 20% of patients received the treatment recommended by clinical practice guidelines. The factors independently associated with appropriate treatment were being treated in cardiology, hypercholesterolemia, age and etiology.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The varied approaches of different specialists, the smaller effort put into diagnosis and therapy in women, and the low percentage of patients treated according to guidelines make it essential that an educational and multidisciplinary strategy should be developed for managing outpatients with heart failure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-Juanatey</LastName><ForeName>Jos&#xe9; R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital Cl&#xed;nico Universitario, Santiago de Compostela, A Coru&#xf1;a, Espa&#xf1;a. jose.ramon.gonzalez.juanatey@sergas.es</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alegr&#xed;a Ezquerra</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials></Author><Author ValidYN="Y"><LastName>Bertom&#xe9;u Mart&#xed;nez</LastName><ForeName>Vicente</ForeName><Initials>V</Initials></Author><Author ValidYN="Y"><LastName>Conthe Guti&#xe9;rrez</LastName><ForeName>Pedro</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>de Santiago Nocito</LastName><ForeName>Ana</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Zsolt Fradera</LastName><ForeName>Ilonka</ForeName><Initials>I</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><VernacularTitle>Insuficiencia cardiaca en consultas ambulatorias: comorbilidades y actuaciones diagn&#xf3;stico-terap&#xe9;uticas por diferentes especialistas. Estudio EPISERVE.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Cardiol</MedlineTA><NlmUniqueID>0404277</NlmUniqueID><ISSNLinking>0300-8932</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002309" MajorTopicYN="N">Cardiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006333" MajorTopicYN="N">Heart Failure</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007388" MajorTopicYN="N">Internal Medicine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010045" MajorTopicYN="N">Outpatients</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015995" MajorTopicYN="N">Prevalence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>6</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>9</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>6</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">18570782</ArticleId><ArticleId IdType="pii">13123067</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">17408167</PMID><DateCompleted><Year>2007</Year><Month>06</Month><Day>29</Day></DateCompleted><DateRevised><Year>2019</Year><Month>11</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0004-0614</ISSN><JournalIssue CitedMedium="Print"><Volume>60</Volume><Issue>1</Issue><PubDate><Year>2007</Year><Season>Jan-Feb</Season></PubDate></JournalIssue><Title>Archivos espanoles de urologia</Title><ISOAbbreviation>Arch Esp Urol</ISOAbbreviation></Journal><ArticleTitle>[Diagnosis and management of patients with overactive bladder syndrome in urology clinics and general practitioner clinics in Spain].</ArticleTitle><Pagination><StartPage>15</StartPage><EndPage>21</EndPage><MedlinePgn>15-21</MedlinePgn></Pagination><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Despite its high prevalence and its important impact on patient's life, overactive bladder is a disorder poorly known and not usually tackled in daily clinical practice. The aim of this study is to know the main procedures and techniques used by both urologists and general practitioners to diagnose overactive bladder in usual clinical practice in Spain.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A standardized questionnaire was administered to 748 physicians specialized in urology and to 696 primary core physicians or general practitioners. The questionnaire collected information about the management of patients who attended surgery with urinary symptoms suggesting overactive bladder.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 64.8% of urologists argued they followed a standardized protocol in order to diagnose patients suffering from overactive bladder. Concerning primary care physicians, 58.4% of them admitted not referring patients with urinary symptoms suggesting overactive bladder to specialist. Up to 77.8% of urologists confirmed that referred patients from primary care had no previous exam or diagnosis. Health history, physical examination and urinalysis were the usual diagnosis procedures in clinical practice conditions for both specialities. Other instruments such as the micturition diary or the questionnaires to assess symptoms or patients' quality of life are still little used for the diagnosis and management of overactive bladder.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Although overactive bladder is a condition that causes a high impairment in the quality of life (QoL) and daily activities of those patients suffering from it, it still remains poorly tackled by doctors. Therefore, it is important to define strategies to detect its symptoms in the clinical practice.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Garc&#xed;a Matres</LastName><ForeName>M Justa</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Servicio de Urolog&#xed;a, Hospital Universitario La Paz, Paseo de la Castellana, 261, 0-28046, Madrid. mjurologa@telefonica.net</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brenes Berm&#xfa;dez</LastName><ForeName>Francisco Jos&#xe9;</ForeName><Initials>FJ</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Diagn&#xf3;stico y manejo de pacientes con s&#xed;ndrome de vejiga hiperactiva en las consultas de urolog&#xed;a y atenci&#xf3;n primaria en Espa&#xf1;a.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Arch Esp Urol</MedlineTA><NlmUniqueID>0064757</NlmUniqueID><ISSNLinking>0004-0614</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005194" MajorTopicYN="N">Family Practice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006268" MajorTopicYN="N">Health Facilities</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011320" MajorTopicYN="N">Primary Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053201" MajorTopicYN="Y">Urinary Bladder, Overactive</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014572" MajorTopicYN="N">Urology</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year><Month>4</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>6</Month><Day>30</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2007</Year><Month>4</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17408167</ArticleId><ArticleId IdType="doi">10.4321/s0004-06142007000100003</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>